Funding for this research was provided by:
Efficacy and Mechanism Evaluation Programme (16/126/26)
Article History
First Online: 12 March 2020
Compliance with Ethical Standards
:
: Dr. A. Mariottini discloses personal fees from Merck-Serono and non-financial support from Biogen Idec, Teva and Novartis. Dr. E. De Matteis reports no conflict of interest. Prof. Paolo A. Muraro discloses travel support and speaker honoraria from unrestricted educational activities organised by Novartis, Bayer HealthCare, Bayer Pharma, Biogen Idec, Merck-Serono and Sanofi Aventis.
: The present work was supported by the National Institute of Health Research (EME Project: 16/126/26 to PM) and the NIHR Biomedical Research Centre funding scheme to Imperial College London.